We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 25, 2021

Metabolic Syndrome Is a Predictor of Recurrence Following Primary Resection of Colorectal Cancer

European Journal of Surgical Oncology

 

Additional Info

European Journal of Surgical Oncology
Metabolic Syndrome Is a Predictor of All Site and Liver-Specific Recurrence Following Primary Resection of Colorectal Cancer: Prospective Cohort Study of 1006 Patients
Eur J Surg Oncol 2021 Jan 07;[EPub Ahead of Print], R Bhome, N Peppa, S Karar, D McDonnell, A Mirnezami, Z Hamady

Further Reading